{
    "SPADE_UN_24659": {
        "Sequence Information": {
            "Peptide Name": "hECP30 [R1,5,17,22,28,30Orn]",
            "Sequence": "XPFTXAQWFAIQHISPXTIAMXAINNYXWX",
            "Sequence Length": 30,
            "Biological Activity": [
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P12724",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P12724",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Rationally Modified Antimicrobial Peptides from the N-Terminal Domain of Human RNase 3 Show Exceptional Serum Stability.",
                    "Pubmed ID": "34342438",
                    "Reference": "J Med Chem. 2021;64:11472-11482",
                    "Author": "Sandín D, Valle J, Chaves-Arquero B, Prats-Ejarque G, Larrosa MN, González-López JJ, Jiménez MA, Boix E, Andreu D, Torrent M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34342438"
                }
            ],
            "SPADE ID": "SPADE_UN_24659",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_24658",
                    "Similarity": 1.0,
                    "Sequence": "FTAQWFAIQHISPTIAMAINNYW"
                },
                {
                    "SPADE_ID": "SPADE_UN_15873",
                    "Similarity": 0.9583333333333334,
                    "Sequence": "RPFTRAQWFAIQHISPRTIAMRAINNYRWR"
                },
                {
                    "SPADE_ID": "SPADE_N_10058",
                    "Similarity": 0.9375,
                    "Sequence": "AQWFAIQHSTIAMRAIN"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:1.1±0.9% Hemolysis=250 µM,Human fibroblasts MRC-5:IC50=230±40 µM",
            "Target Organism": "Escherichia coli BW25113(MIC=3.13µM),Acinetobacter baumannii ATCC 15308(MIC=12.5µM),Pseudomonas sp. ATCC 15915(MIC=1.56µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MIC=50µM),Shigella flexneri ATCC 29903(MIC=50µM),Escherichia coli CFT073(MIC=6.25-25µM),Pseudomonas aeruginosa(MIC=25µM),Salmonella typhimurium(MIC=25µM),Acinetobacter baumannii(MIC=0.78-12.5µM),Escherichia coli BW25113(MBC=3.13µM),Acinetobacter baumannii ATCC 15308(MBC=12.5µM),Pseudomonas sp. ATCC 15915(MBC=1.56µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MBC=50µM),Shigella flexneri ATCC 29903(MBC=50µM)"
        }
    }
}